Downregulation of the transcription factor scleraxis in brain of patients with Down Syndrome

Journal of Neural Transmission, Supplement

Volumn , Issue 57, 1999, Pages 305-314

  Yeghiazaryan, K ^d   Turhani Schatzmann, D ^d   Labudova, O ^d   Schuller, E ^d   Olson, E N ^a   Cairns, N ^b   Lubec, G ^c  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY OF VIENNA   (Austria)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

BETA ACTIN; HELIX LOOP HELIX PROTEIN; MESSENGER RNA; SCLERAXIS; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; BASIC HELIX LOOP HELIX TRANSCRIPTION FACTOR; RECOMBINANT PROTEIN; SCXA PROTEIN, HUMAN;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; CEREBELLUM; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN SYNDROME; FEMALE; FETUS; FRONTAL LOBE; HOUSEKEEPING GENE; HUMAN; HUMAN TISSUE; MALE; NERVE CELL PLASTICITY; NERVE DEGENERATION; NEUROPATHOLOGY; NUCLEOTIDE SEQUENCE; OCCIPITAL LOBE; PARIETAL LOBE; PATHOGENESIS; PRIORITY JOURNAL; SEQUENCE HOMOLOGY; STEADY STATE; TEMPORAL LOBE; AMINO ACID SEQUENCE; BIOSYNTHESIS; CHEMISTRY; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GENETICS; GESTATIONAL AGE; MOLECULAR CLONING; MOLECULAR GENETICS; PATHOLOGY; PRENATAL DEVELOPMENT; REFERENCE VALUE; SEQUENCE ALIGNMENT;

ADULT; ALZHEIMER DISEASE; AMINO ACID SEQUENCE; BASE SEQUENCE; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; CLONING, MOLECULAR; DOWN SYNDROME; FETUS; GENE EXPRESSION REGULATION; GESTATIONAL AGE; HELIX-LOOP-HELIX MOTIFS; HUMANS; MOLECULAR SEQUENCE DATA; NERVE DEGENERATION; RECOMBINANT PROTEINS; REFERENCE VALUES; RNA, MESSENGER; SEQUENCE ALIGNMENT; SEQUENCE HOMOLOGY, NUCLEIC ACID; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC;

EID: 0032585821     PISSN: 03036995     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-3-7091-6380-1_21     Document Type: Article

References (32)

1. Adams MD, Kelley JM, Gocayne JD, Dubnick M, Polymeropoulos MH, Xiao H, Merril CR, Wu A, Olde BO, Moreno RF, Kerlavage AR, McCombie WR, Venter JC (1991) Complementary DNA sequencing: expressed sequence tags and human genome project. Science 252: 1651-1656
2. Adams MD, Dubnick M, Kerlavage AR, Moreno R, Kelley JM, Utterback RT, Nagle JW, Fields C, Venter JC (1992) Sequence identification of 2,375 human brain genes. Nature 355: 632-634
3. Arenander AT, De Vellis J (1994) Development of the nervous system. In: Siegel GJ, Agranoff BW, Albers RW, Molinoff PB (eds) Basic neurochemistry, 5th edn. Raven Press, New York, pp 573-606
4. Burger PC, Vogel FS (1973) The development of pathologic changes of Alzheimer's disease and senile dementia in patients with Down's syndrome. Am J Pathol 73: 457-476
5. Busciglio J, Yankner BA (1995) Apoptosis and increased generation of reactive oxygen species in Down's syndrome neurons in vitro. Nature 378: 776-779
6. Cserjesi P, Brown D, Ligon KL, Lyons GE, Copeland NG, Gilbert DJ, Jenkins NA, Olson EN (1995) Scleraxis: a basic helix-loop-helix protgein that prefigures skeletal formation during mouse embryogenesis. Development 121: 1099-1110
7. Epstein CJ (1992) Down Syndrome (Trisomy 21) In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds) The metabolic and molecular basis of inherited disease. McGraw Hill, New York, pp 749-794
8. Fang-Kircher S, Labudova O, Kitzmueller E, Rink H, Cairns N, Lubec G (1999) Increased steady state mRNA levels of DNA repair genes XRCC1, ERCC2 and ERCC3 in brain of patients with Down Syndrome. Life Sci (in press)
9. Hardmeier R, Hoeger H, Fang-Kircher S, Khoshsorur A, Lubec G (1997) Transcription and activity of superoxide dismutase, catalase and glutathione peroxidase following irradiation in radiation resistant and radiation sensitive mice Proc. Natl Acad Sci (USA) 94: 7572-7576
10. He X, Rosenfeld MG (1991) Mechanisms of complex transcriptional regulation: implications for brain development. Neuron 7: 183-196
11. Kim TW, Pettingell WH, Jung YK, Kovacs DM, Tanzi RE (1997) Alternative cleavage of Alzheimer-associated presenilins during apoptosis by a caspase - 3 family protease. Science 277: 373-376
12. Kitamura Y, Shimohama S, Kamoshima W, Ota T, Matsuoka Y, Nomura Y, Smith MA, Perry G, Whithouse PJ, Taniguchi T (1998) Alteration of proteins regulating apoptosis, bcl-2, bcl-x, bax, bak, bad, ICH-1 and CPP32 in Alzheimer's disease. Brain Res 780: 260-269
13. Kola I, Christiano F, de Haan JB, Thomas R, Sumarsono S, Corrick CM, Tymms M (1995) Genes, embryogenesis and Down Syndrome. In: Moeloek FA, Affandi B, Trounson AO (eds) Advances in human reproduction. Casterton-Parthenon, NY, pp 309-320
14. Labudova O, Lubec G (1998) cAMP upregulates the transposable element mys-1: a possible link between signaling and mobile DNA. Life Sci 62: 431-437
15. Labudova O, Fang-Kircher S, Cairns N, Lubec G (1998) Upregulation of vasopressin in brain of patients with Down Syndrome. Brain Res 806: 55-59
16. Labudova O, Krapfenbauer K, Moenkemann H, Rink H, Kitzmueller E, Cairns N, Lubec G (1998) Decreased transcription factor junD in brain of patients with Down Syndrome. Neurosci Lett 252: 159-162
17. Liu Y, Cserjesi P, Nifuji A, Olson EN, Noda M (1996) Sclerotome-related helix-loop-helix type transcription factor (scleraxis) mRNA is expressed in osteoblasts and its level is enhanced by type-beta transforming growth factor. J Endocrinol 151: 491-499
18. Liu Y, Nifuji A, Tamura M, Wozney JM, Olson EN, Noda M (1997) Scleraxis messenger ribonucleic acid is expressed in C2C12 myoblasts and its level is down-regulated by bone morphogenetic protein - 2 (BMP2). J Cell Biochem 67: 66-74
19. Liu Y, Watanabe H, Nifuji A, Yamada Y, Olson EN, Noda M (1997) Overexpression of a single helix-loop-helix type transcription factor, scleraxis, enhances aggrecan gene expression in osteoblastic osteosarcoma ROS17/2.8 cells. J Biol Chem 272: 29880-29885
20. Ma L, Westbroek A, Jochemsen AG, Weeda G, Bosch A, Bootsma D, Hoeijmakers JHJ, van der Erb AJ (1994) Mutational analysis of ERCC3, which is involved in DNA repair and transcription initiation: identification of domains essential for the DNA repair function. Mol Cell Biol 14: 4126-4134
21. McMaster GK, Carmichael GG (1977) Analysis by single and double stranded nucleic acids on polyacrylamide and agarose gels by using glyoxal and acridine orange. Proc Natl Acad Sci (USA) 74: 4835-4841
22. Mirra SS, Heyman A, McKeel D, Sumi S, Crain BJ (1991) The consortium to establish a registry for Alzheimer disease (CERAD). II. Standardisation of the neuropathological assessment of Alzheimer's disease. Neurology 41: 479-486
23. Morris BJ (1997) Neuronal plasticity. In: Davies RW, Morris BJ (eds) Molecular biology of the neuron. Bios Scientifique Publishers, Oxford, pp 323-335
24. Nagy ZS, Esiri MM (1997) Apoptosis - related protein expression in the hippocampus in Alzheimer's disease. Neurobiol Aging 18: 565-571
25. Schaeffer L, Moncollin V, Roy R, Staub A, Mezzina M, Sarasin A, Weeda G, Hoeijmakers JHJ, Egly JM (1994) The ERCC2 / DNA repair protein is associated with the class II BTF2 / TFIIH transcription factor. EMBO J 13: 2388-2392
26. Seidl R, Greber S, Schuller E, Bernert G, Cairns N, Lubec G (1997) Evidence against increased oxidative DNA damage in Down Syndrome. Neurosci Lett 235: 137-140
27. Southern EM (1975) Detection of specific sequences among DNA fragments separated by gel electrophoresis. J Mol Biol 98: 503-511
28. Tierney MC, Fisher RH, Lewis AJ, Torzitto ML, Snow WG, Reid DW, Nieuwstraaten P, Van Rooijen LAA, Derks HJGM, Van Wijk R, Bischop A (1988) The NINCDA-ADRDA work group criteria for the clinical diagnosis of probable Alzheimer's disease. Neurology 38: 359-364
29. Wang XW, Vermeulen W, Coursen JD, Gibson M, Lupold SE, Forrester K, Xu G, Elmore L, Yeh H, Hoeijmakers JHJ, Harris CC (1996) The XPB and XPD DNA helicases are components of the p53 mediated apoptosis pathway. Genes Dev 10: 1219-1232
30. Warbrick E (1996) Apoptosis: a new twist to the tale? Curr Biol 6: 1057-1059
31. White BA, Bancroft FC (1982) Cytoplasmic dot hybridization. Simple analysis of mRNA levels in multiple small cell or tissue samples. J Biol Chem 257: 8569-8574
32. Wisniewski KE, Wisniewski HM, Wen GY (1985) Occurrence of neuropathological changes and dementia of Alzheimer's disease in Down's syndrome. Ann Neurol 17: 278-282